Trusted by:

clients clients clients clients clients clients clients clients clients clients
Released: 29-Oct-2024 6:25 PM EDT
Most Patients Can Continue Diabetes, Weight Loss GLP-1 Drugs Before Surgery, Those at Highest Risk for GI Problems Should Follow Liquid Diet Before Procedure
American Society of Anesthesiologists (ASA)

Most patients should continue taking their glucagon-like peptide-1 (GLP-1) receptor agonists before elective surgery, suggests new clinical guidance released by the American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons. Patients at the highest risk for significant gastrointestinal (GI) side effects should follow a liquid diet for 24 hours before the procedure or other measures, depending on the specific circumstances.

Newswise: Collaboration Speeds Complex Chemical Modeling
Released: 29-Oct-2024 4:20 PM EDT
Collaboration Speeds Complex Chemical Modeling
Pacific Northwest National Laboratory

A recent collaboration among researchers from HUN-REN Wigner Research Centre for Physics in Hungary and the Department of Energy’s Pacific Northwest National Laboratory, along with industry collaborators SandboxAQ and NVIDIA, has achieved unprecedented speed and performance in efforts to model complex metal-containing molecules.

Newswise: New Computational Method Links One Mammal’s Striking Longevity and Resistance to Cancer With ‘Dark Genome’
Released: 29-Oct-2024 4:00 PM EDT
New Computational Method Links One Mammal’s Striking Longevity and Resistance to Cancer With ‘Dark Genome’
Roswell Park Comprehensive Cancer Center

The Roswell Park team has developed a new method to measure mutation loads across species, revealing the role of the "dark genome" — ancient, virus-like genes that affect cellular function. The findings support further exploration of antiviral drugs as potential tools to target the dark genome in controlling cancer.

Newswise: Computational Tool Developed to Predict Immunotherapy Outcomes for Patients With Metastatic Breast Cancer
Released: 29-Oct-2024 2:00 PM EDT
Computational Tool Developed to Predict Immunotherapy Outcomes for Patients With Metastatic Breast Cancer
Johns Hopkins Medicine

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy.

Newswise: UTEP Student Develops Award-winning Method to Desalinate Water
Released: 29-Oct-2024 1:05 PM EDT
UTEP Student Develops Award-winning Method to Desalinate Water
University of Texas at El Paso

Tayia Oddonetto, a doctoral student at The University of Texas at El Paso, developed electrodialysis metathesis, a novel approach to the desalination of brine, or salt, water that can convert over 90% of salt water to fresh water. The research earned Oddonetto first place and funding from the NSF Engineering Research Centers Perfect Pitch Competition.

Released: 29-Oct-2024 12:00 PM EDT
Inflammatory Bowel Disease: The Crucial Period of Early Childhood
Universite de Montreal

Breastfeeding, child nutrition and exposure secondhand tobacco smoke at an early age may play a role in the onset of inflammatory bowel disease, according to a study conducted on Quebecers.

Released: 29-Oct-2024 11:50 AM EDT
Transcatheter Aortic Valve Replacement in Patients with Systolic Heart Failure and Moderate Aortic Stenosis Shows Limited Benefits
Cardiovascular Research Foundation (CRF)

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS). Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. The results were also published simultaneously in the Journal of the American College of Cardiology.

Released: 29-Oct-2024 11:40 AM EDT
Early Intervention in Patients with Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis Falls Short of Expected Benefits
Cardiovascular Research Foundation (CRF)

The EVOLVED trial found that early aortic valve intervention in patients with asymptomatic severe aortic stenosis (AS) and mid-wall myocardial fibrosis on magnetic resonance imaging did not reduce the incidence of the composite primary endpoint of all-cause death or unplanned aortic stenosis hospitalization compared with guideline-directed conservative management. Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. The results were also published simultaneously in the Journal of the American Medical Association.

Released: 29-Oct-2024 11:35 AM EDT
Study Finds Early TAVR Can Be Beneficial for Patients with Asymptomatic Severe Aortic Stenosis
Cardiovascular Research Foundation (CRF)

The first powered randomized trial examining early intervention with transcatheter aortic valve replacement (TAVR) in patients with asymptomatic, severe aortic stenosis (AS) found this strategy to be both a safe and effective alternative to clinical surveillance (CS). Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. Results were also published simultaneously in the New England Journal of Medicine.

Released: 29-Oct-2024 11:00 AM EDT
Treating Severe Calcification With an Atherectomy Device Does Not Improve Cardiac Stenting Outcomes, Study Finds
Mount Sinai Health System

First-of-its kind work led by Mount Sinai researcher supports reserving this technique for extreme cases


close
1.16169